Vizora日本語

Daito PharmaceuticalDaito Pharmaceutical Co., Ltd.4577東証プライム医薬品FY ending May 2026, consolidated, J-GAAP

Daito Pharmaceutical FY ending May 2025 results

Daito Pharmaceutical brought in ¥50.6B in revenue.

Out of every ¥100 of sales, about ¥5 is left as operating profit.

Revenue changed +8.0% from the prior year, operating profit -32.7%.

Revenue and profit pattern

Revenue up, profit downRevenue grew faster

Revenue +8.0% · profit -32.7%, calculated from disclosed figures.

Operating leverage: -4.10× (profit growth ÷ revenue growth)

What changed from last year

FY ending May 2024 → FY ending May 2025

Revenue
+8.0%¥46.9B → ¥50.6B
Gross profit
-12.2%¥9.84B → ¥8.64B
Operating income
-32.7%¥3.89B → ¥2.62B
Net income attributable to owners
-42.1%¥3.29B → ¥1.91B
Operating cash flow
+13.8%¥5.18B → ¥5.9B
Free cash flow
Loss-¥1.09B → -¥1.13B

Where the money goes

FY ending May 2024 → FY ending May 2025

Where ¥100 of sales goes

For every ¥100 Daito Pharmaceutical sells, how much goes where, and how much is kept.

FY ending May 2025
Cost of sales
¥83
SG&A
¥12
Operating profit
¥5
Net profit kept
¥4

Annual margin trends

Gross margin17.1%
FY ending May 2020: 21.1%21.1%FY ending May 2021: 22.2%22.2%FY ending May 2022: 26.4%26.4%FY ending May 2023: 22.9%22.9%FY ending May 2024: 21.0%21.0%FY ending May 2025: 17.1%17.1%FY20FY21FY22FY23FY24FY25
Operating margin5.2%
FY ending May 2020: 11.9%11.9%FY ending May 2021: 12.1%12.1%FY ending May 2022: 15.1%15.1%FY ending May 2023: 11.5%11.5%FY ending May 2024: 8.3%8.3%FY ending May 2025: 5.2%5.2%FY20FY21FY22FY23FY24FY25
Net margin3.8%
FY ending May 2020: 8.8%8.8%FY ending May 2021: 8.7%8.7%FY ending May 2022: 10.7%10.7%FY ending May 2023: 8.0%8.0%FY ending May 2024: 7.0%7.0%FY ending May 2025: 3.8%3.8%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第84期(2025/06/01－2026/05/31)

    ID S100YYNI2026-08-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第83期(2024/06/01－2025/05/31)

    ID S100WLMY2025-08-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第82期(2023/06/01－2024/05/31)

    ID S100UAWW2024-08-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第81期(2022/06/01－2023/05/31)

    ID S100RS132023-08-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第80期(令和3年6月1日－令和4年5月31日)

    ID S100P2X32022-08-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第79期(令和2年6月1日－令和3年5月31日)

    ID S100MCBH2021-08-26Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image